Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Response Biomed Corp RPBIF

"Response Biomedical Corp is engaged in the research, development, commercialization and distribution of diagnostic technologies for the medical central-lab testing, point of care (POC) testing and on-site environmental testing markets."


GREY:RPBIF - Post by User

Bullboard Posts
Post by dimar66on Sep 04, 2011 3:53pm
292 Views
Post# 19011085

US Distribution

US Distribution
I view the termination of the relationship with Roche to be a positive, already world distribution rights have been clawed back including distribution in Canada which is now done by  Fisher Scientific.  We haven't heard much from our other partners in the US, 3M, so one wonders if there is any revenue happening there; but it appears that 3M is continuing to market the Ramp tests.
https://solutions.3m.com/wps/portal/3M/en_US/Medical-Diagnostics/Medical-Diagnostics/Product-Information/Rapid-Detection-Products/
Demonstration Video on Ramp
https://mothra.implex.net/3mhealthcare/Flu_Test_WebStream_300.wmv
Bullboard Posts